1. Home
  2. AEP vs TAK Comparison

AEP vs TAK Comparison

Compare AEP & TAK Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo American Electric Power Company Inc.

AEP

American Electric Power Company Inc.

N/A

Current Price

$125.88

Market Cap

70.3B

Sector

Utilities

ML Signal

N/A

Logo Takeda Pharmaceutical Company Limited (each representing 1/2 of a share of)

TAK

Takeda Pharmaceutical Company Limited (each representing 1/2 of a share of)

N/A

Current Price

$21.82

Market Cap

69.1B

Sector

Health Care

ML Signal

N/A

Company Overview

Basic Information
Metric
AEP
TAK
Founded
1906
1781
Country
United States
Japan
Employees
N/A
N/A
Industry
Electric Utilities: Central
Biotechnology: Pharmaceutical Preparations
Sector
Utilities
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
70.3B
69.1B
IPO Year
2000
2007

Fundamental Metrics

Financial Performance
Metric
AEP
TAK
Price
$125.88
$21.82
Analyst Decision
Buy
Strong Buy
Analyst Count
23
3
Target Price
★ $141.61
$24.48
AVG Volume (30 Days)
★ 3.6M
3.1M
Earning Date
10-28-2026
10-29-2026
Dividend Yield
★ 3.10%
1.12%
EPS Growth
★ 19.35
N/A
EPS
★ 1.60
N/A
Revenue
★ $21,876,000,000.00
N/A
Revenue This Year
$7.59
$4.79
Revenue Next Year
$5.53
$2.44
P/E Ratio
$78.11
★ $41.25
Revenue Growth
★ 10.93
N/A
52 Week Low
$112.54
$14.16
52 Week High
$140.58
$21.86

Technical Indicators

Market Signals
Indicator
AEP
TAK
Relative Strength Index (RSI) 44.79 69.50
Support Level $123.26 $17.66
Resistance Level $129.06 N/A
Average True Range (ATR) 2.77 0.33
MACD -0.62 -0.01
Stochastic Oscillator 24.12 82.22

Price Performance

Historical Comparison
AEP
TAK

About AEP American Electric Power Company Inc.

American Electric Power is one of the largest regulated utilities in the United States, providing electricity generation, transmission, and distribution to more than 5 million customers in 11 states. About 39% of AEP's capacity is coal, with the remainder from a mix of natural gas (28%), renewable energy and hydro (23%), nuclear (7%), and demand response (3%). Vertically integrated utilities, transmission and distribution, and generation and marketing support earnings.

About TAK Takeda Pharmaceutical Company Limited (each representing 1/2 of a share of)

Takeda Pharmaceutical is Japan's largest pharmaceutical company, with revenue of JPY 4.5 trillion in fiscal 2025. The company's five core therapeutic areas are oncology, gastroenterology, neuroscience, rare diseases, and plasma-derived therapies, which account for more than 80% of revenue. Its geographic footprint is well diversified, with about 50% from the US, 10% from Japan, 25% from Europe, and 15% from Canada.

Share on Social Networks: